Drug recall · August 26, 2026
PEMRYDI RTU recall
Why: Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1
- Lots / codes
Lot: P400172; Lot PA00050A, Exp 09/30/2027
- Quantity
- 18,434 10mL vials
- Company
- Shilpa Medicare Limited, Jadcherla, Mahabubnagar District
- Distribution
- Nationwide in the USA.
- Initiated
- July 29, 2026 · Voluntary: Firm initiated
- Classified
- August 14, 2026
- Reported
- August 26, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pemetrexed
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.